Publications by authors named "Sharon Munn"

Claim this Profile
C
Chemical selection for the Thyroid Validation Study coordinated by EURL ECVAM and involving EU-NETVAL laboratories.
Camilla Bernasconi, Stavroula Sampani, Anna Beronius, Sandra Coecke, Ingrid Langezaal, Sharon Munn

ALTEX· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The benefits of validation of methods for toxicity testing outweigh its costs.
Anne Gourmelon, Philippe Hubert, Elise Grignard, Lisa Baumann, Sharon Munn

ALTEX· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OECD harmonised template 201: Structuring and reporting mechanistic information to foster the integration of new approach methodologies for hazard and risk assessment of chemicals.
Edoardo Carnesecchi, Ingrid Langezaal, Patience Browne, Sofia Batista-Leite, Ivana Campia, Sharon Munn

Regul Toxicol Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
Francesca Pistollato, Federica Madia, Raffaella Corvi, Sharon Munn, Elise Grignard

Arch Toxicol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory needs and activities to address the retinoid system in the context of endocrine disruption: The European viewpoint.
Elise Grignard, Helen Håkansson, Sharon Munn

Reprod Toxicol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
Anna Bal-Price, Francesca Pistollato, Magdalini Sachana, Stephanie K Bopp, Sharon Munn

Toxicol Appl Pharmacol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse outcome pathway networks I: Development and applications.
Dries Knapen, Michelle M Angrish, Marie C Fortin, Ioanna Katsiadaki, Marc Leonard, Sharon Munn

Environ Toxicol Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse outcome pathway networks II: Network analytics.
Daniel L Villeneuve, Michelle M Angrish, Marie C Fortin, Ioanna Katsiadaki, Marc Leonard, Sharon Munn

Environ Toxicol Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009.

EFSA J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing the adverse outcome pathway framework-An international horizon scanning approach.
Carlie A LaLone, Gerald T Ankley, Scott E Belanger, Michelle R Embry, Geoff Hodges, Sharon Munn

Environ Toxicol Chem· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse outcome pathway development from protein alkylation to liver fibrosis.
Tomislav Horvat, Brigitte Landesmann, Alfonso Lostia, Mathieu Vinken, Sharon Munn

Arch Toxicol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse outcome pathways: From research to regulation scientific workshop report.
Nicole C Kleinstreuer, Kristie Sullivan, David Allen, Stephen Edwards, Donna L Mendrick, Sharon Munn

Regul Toxicol Pharmacol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical Safety Assessment Using Read-Across: Assessing the Use of Novel Testing Methods to Strengthen the Evidence Base for Decision Making.
Elisabet Berggren, Patric Amcoff, Romualdo Benigni, Karen Blackburn, Edward Carney, Sharon Munn

Environ Health Perspect· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse outcome pathway (AOP) development I: strategies and principles.
Daniel L Villeneuve, Doug Crump, Natàlia Garcia-Reyero, Markus Hecker, Thomas H Hutchinson, Sharon Munn

Toxicol Sci· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse outcome pathway development II: best practices.
Daniel L Villeneuve, Doug Crump, Natàlia Garcia-Reyero, Markus Hecker, Thomas H Hutchinson, Sharon Munn

Toxicol Sci· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the risk of exposures to endocrine disrupting chemicals.
Sharon Munn, Jerrold Heindel

Chemosphere· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary.
Claire Beausoleil, Jean-Nicolas Ormsby, Andreas Gies, Ulla Hass, Jerrold J Heindel, Sharon Munn

Chemosphere· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
Agnieszka Kinsner-Ovaskainen, Gavin Maxwell, Joachim Kreysa, João Barroso, Els Adriaens, Sharon Munn

Altern Lab Anim· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
Sarah Adler, David Basketter, Stuart Creton, Olavi Pelkonen, Jan van Benthem, Sharon Munn

Arch Toxicol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Guyton, Kathryn Z., Barone, Stanley, Jr., Brown, Rebecca C., Euling, Susan Y., Jinot, Jennifer, Makris, Susan (2008). Mode of action frameworks: a critical analysis. Journal of Toxicology and Environmental Health, Part B, 11(1): 16-31.
M E Meek, Colin Berry, Alan R Boobis, Samuel M Cohen, Margaret Hartley, Sharon Munn

J Toxicol Environ Health B Crit Rev· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IPCS framework for analyzing the relevance of a noncancer mode of action for humans.
Alan R Boobis, John E Doe, Barbara Heinrich-Hirsch, M E Bette Meek, Sharon Munn

Crit Rev Toxicol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54.
Sandra Coecke, Hans Ahr, Bas J Blaauboer, Susanne Bremer, Silvia Casati, Sharon Munn

Altern Lab Anim· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EU risk assessment: science and policy.
Sharon Janette Munn, Bjorn Gaarn Hansen

Toxicology· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis